Stuart Burri, M.D.

508 posts

Stuart Burri, M.D.

Stuart Burri, M.D.

@stuxrt

Dad, husband, Radiation Oncologist with Southeast Radiation Oncology and Levine Cancer Institute @atriumhealth @levinecancer. Of course, the opinions are mine

Katılım Mayıs 2011
549 Takip Edilen647 Takipçiler
Stuart Burri, M.D. retweetledi
Dan Trifiletti, MD
Dan Trifiletti, MD@DanTrifMD·
🔔⏰ Welcome to #ASTRO2025 ⏰ 🔔 Honored to sit on the stage in front of a big crowd while we learn from @ChristyCramerMD @stuxrt @joshuapalmermd If you’re on your way get excited, tons of great presentations planned and networking opportunities. And also perfect weather 💪
English
2
4
27
964
Stuart Burri, M.D. retweetledi
OncoAlert
OncoAlert@OncoAlert·
Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer out on Lancet Oncology buff.ly/4huOHek Multicentre, single-arm phase 2 trial evaluated the safety and efficacy of a novel treatment approach for patients with unresectable, locally advanced non-small-cell #LungCancer ( #NSCLC ), involving stereotactic body radiotherapy (SBRT) to the primary tumor, followed by standard chemoradiotherapy to the lymph nodes and consolidation immunotherapy with durvalumab. Sixty-one patients were enrolled, with a median follow-up of 29.5 months. The study reported a 1-year progression-free survival (PFS) of 62.7%, although it did not achieve the primary endpoint of significant improvement over historical controls. Treatment-related grade 3–4 adverse events included decreased neutrophil and white blood cell counts, and treatment-related deaths occurred in 7% of patients. Despite not meeting the primary endpoint, the treatment demonstrated favorable activity and safety profiles, forming the basis for an ongoing randomized phase 3 trial (NRG Oncology LU008). @DrJRadOnc @KMilehamMD @DrChrisCorso @AKesarwala @stuxrt Ping OncoAlert Rad Onc Faculty @MKnoll_MD @HenningWillers @fumikochino @_ShankarSiva @PercyLeeMD @Icro_Meattini @DrChowdharyMD @DrLesterColl @ErinGillespieMD @seanmmcbride @NiuSanford #OncoAlertAF @nataliagandur @acampsmalea @BiagioRicciutMD @yekeduz_emre @HHorinouchi @FadiHaddad_MD @Dr_Ivanoncologo @Abdallah81MD @FernandoOnco @ElisaAgostinett @to_be_elizabeth @bavilima @realbowtiedoc @Erman_Akkus @Lucarecco @GaiaGriguolo @JankovicK
OncoAlert tweet media
English
0
23
51
5.2K
Stuart Burri, M.D. retweetledi
Stuart Burri, M.D.
Stuart Burri, M.D.@stuxrt·
Plus in medullo has the theoretical benefit of reducing surgical perturbation failure - much like seems to be the case for brain metastases
Joshua D. Palmer, MD@joshuapalmermd

@cristian_udo @MohitKasibhatla @RO_GreenJournal @HaghighiNeda @PeterMacRadOnc @PeterMacCC @PeterMacRes @svporceddu @celloradonc @JMBryantMD @DrPinky_UK @DanTrifMD @MayoClinic @MayoFL_RORes @TheChristieNHS @gerbenborst @stuxrt @ErinMurphyMD @RoshanPrabhu07 Agree I love the idea for other histology, personally I think best for medullo and gbm first but could be good for others. Have seen complete responses in preop for medullo

English
0
1
7
520
Stuart Burri, M.D. retweetledi
Levine Cancer
Levine Cancer@LevineCancer·
The power of proton is HERE! 🎉 We're proud to be the first & only program in the Carolinas to offer this state-of-the-art treatment. Our first 2 patients, Dakota & Hunter helped us cut the ribbon on this new service today! Link to learn more: bit.ly/3Y8IVa8
Levine Cancer tweet mediaLevine Cancer tweet mediaLevine Cancer tweet mediaLevine Cancer tweet media
English
0
5
20
1K